AVIR — ATEA PHARMACEUTICALS INC

Ownership history in MACQUARIE GROUP LTD  ·  17 quarters on record

This page tracks every 13F SEC filing in which MACQUARIE GROUP LTD reported a position in ATEA PHARMACEUTICALS INC (AVIR). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q3 UNCHANGED 70,000 — 0% 0.00% $203K $2.90
2025 Q2 UNCHANGED 70,000 — 0% 0.00% $252K $3.60
2025 Q1 UNCHANGED 70,000 — 0% 0.00% $209K $2.99
2024 Q4 UNCHANGED 70,000 — 0% 0.00% $235K $3.35
2024 Q3 UNCHANGED 70,000 — 0% 0.00% $235K $3.35
2024 Q2 UNCHANGED 70,000 — 0% 0.00% $232K $3.31
2024 Q1 UNCHANGED 70,000 — 0% 0.00% $283K $4.04
2023 Q4 UNCHANGED 70,000 — 0% 0.00% $214K $3.05
2023 Q3 UNCHANGED 70,000 — 0% 0.00% $210K $3.00
2023 Q2 UNCHANGED 70,000 — 0% 0.00% $262K $3.74
7 older quarters hidden  —  Sign in free or upgrade to Premium to see full history
% of Fund (quarterly)    AVIR price (monthly, adj. close)

Other funds also holding AVIR

As of 2025 Q4 — sorted by position size

BML Capital Management, LLC 3Y 23.11% CM Management, LLC 3Y 1.07% TANG CAPITAL MANAGEMENT LLC 3Y 7Y 0.85% Bain Capital Life Sciences Investors, LLC 3Y 7Y 0.68% Aldebaran Capital, LLC 3Y 0.29% Rangeley Capital, LLC 0.24% Auour Investments LLC 0.2% NANO CAP NEW MILLENNIUM GROWTH FUND L P 0.15% Opaleye Management Inc. 3Y 7Y 0.08% Sunpointe, LLC 0.01%
← Back to MACQUARIE GROUP LTD Holdings